Sign in to view content

Brolucizumab: Will it Make a Differance

Andrew P. Schachat, MD

Video
Published 2018

Related

The Changing Avastin Landscape
Paul Hahn, MD, PhD, FASRS
Annual Meeting Talks
2019
New Biosimilar Bevacizumab and Ranibizumab for Retinal Diseases
Alay S. Banker, MD
Annual Meeting Talks
2018
Evaluation of Treatment of High Risk Proliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection (ELYSIAN)
Victor Hugo Gonzalez, MD
On Demand Cases, Courses, and Papers
2018

Category: AMD-Neovascular

See more